Posts Tagged: Buffy Wicks
Podcast
CAPITOL WEEKLY PODCAST: Today we welcome CalMatters’ new editor in chief, Kristen Go, who joined the newsroom at the end of May. We asked her about her vision for CalMatters, how the nonprofit news model stacks up against traditional media, and about AB 886, Asm. Buffy Wicks’ proposal to force tech giants to fund reporting.
News
Women have never achieved parity with their male colleagues in the California Legislature. Many advocates believe that could change before the end of the decade, but getting there is hardly a given.
News
This is the second in a series looking at efforts to reach gender parity in the California Legislature. Today we offer a closer look at one of the biggest challenges female candidates and officeholders face – parenting. Read Part I here.
Running for office was one of the scariest experiences of
News
Advocates for greater gender parity in California politics believe that women could reach 50 percent – or beyond – before the end of the decade. On Election Day 2022, women took 11 seats previously held by men, three in the Senate and eight in the Assembly, bringing the total number of women in the Legislature to 50, or 42 percent of the membership.
Podcast
CAPITOL WEEKLY PODCAST: This Special Episode of the Capitol Weekly Podcast was recorded live at Capitol Weekly’s Conference on Housing, and presents the Keynote for the event: A conversation between Asm. Buffy Wicks and Hannah Wiley of the Los Angeles Times.
Podcast
CAPITOL WEEKLY PODCAST: This Special Episode of the Capitol Weekly Podcast was recorded live at Capitol Weekly’s Conference on Housing, and presents Panel 1: Office to Housing Conversion.
News
In 1986, when California voters approved Proposition 65, they effectively enacted a nationwide law, whether they intended to or not. The ballot measure, known as the Safe Drinking Water and Toxic Enforcement Act of 1986, requires all businesses, including product manufacturers, to warn Californians about any significant exposures to chemicals that could cause cancer, birth defects or reproductive harm.